Literature DB >> 2481651

Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer.

M Xu1, F X Real, S Welt, M H Schüssler, H F Oettgen, L J Old.   

Abstract

Monoclonal antibody (MAb) B72.3 detects an epitope carried by high-molecular-weight mucins (tumor-associated glycoprotein, TAG-72) recently identified as sialyl-Tn. B72.3 MAb has a restricted pattern of reactivity with normal tissues but it reacts with a high proportion of epithelial cancers. To determine the possible relationship between neoplastic transformation and reactivity with B72.3 MAb, we have analyzed samples of normal colon, colon cancer and transitional mucosa (mucosa adjacent to colorectal cancer) or reactive mucosa (mucosa adjacent to squamous carcinoma of the anal canal, or mucosa overlying lymphoma). B72.3 MAb reacted strongly with 21/21 specimens of transitional mucosa and with 17/21 specimens of adjacent colon cancer. Reactivity of B72.3 MAb with transitional mucosa was strong and homogeneous, whereas reactivity with cancer tissue was weaker and more heterogeneous. Reactive mucosa adjacent to squamous carcinoma or lymphoma was also reactive with B72.3 MAb. Our findings show that, in the colon, expression of TAG-72 antigen occurs during the process of epithelial cell transformation but is also regulated by factors unrelated to the process of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481651     DOI: 10.1002/ijc.2910440607

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.

Authors:  G Ragupathi; R R Koganty; D Qiu; K O Lloyd; P O Livingston
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

2.  CAM 17.1--a new diagnostic marker in pancreatic cancer.

Authors:  F Gansauge; S Gansauge; N Parker; M I Beger; B Poch; K H Link; F Safi; H G Beger
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 3.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

4.  Immunohistochemical examination of anti-STn monoclonal antibodies LLU9B4, B72.3, and B35.2 for their potential use as tumor markers.

Authors:  Keshab D Pant; Ankur Jain; John D McCracken; Kevin Thompson
Journal:  Dig Dis Sci       Date:  2008-02-26       Impact factor: 3.199

Review 5.  The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer.

Authors:  Q A Wang; H Gao; Y H Wang; Y L Chen
Journal:  Jpn J Surg       Date:  1991-05

6.  Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.

Authors:  Hannah M Hollandsworth; Hiroto Nishino; Michael Turner; Siamak Amirfakhri; Filemoni Filemoni; Robert M Hoffman; Paul J Yazaki; Michael Bouvet
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 7.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

8.  In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme.

Authors:  James C Knight; Michael Mosley; H Tetsuo Uyeda; Mei Cong; Frank Fan; Stephen Faulkner; Bart Cornelissen
Journal:  Mol Pharm       Date:  2017-06-08       Impact factor: 4.939

9.  Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis.

Authors:  H Kitamura; S Yonezawa; S Tanaka; Y S Kim; E Sato
Journal:  Jpn J Cancer Res       Date:  1996-06

Review 10.  The expansion of targetable biomarkers for CAR T cell therapy.

Authors:  Michelle H Townsend; Gajendra Shrestha; Richard A Robison; Kim L O'Neill
Journal:  J Exp Clin Cancer Res       Date:  2018-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.